Review in The Lancet finds that one in five globally are at risk of contracting cardiovascular diseases, because they carry a genetic risk of high levels of a specific lipoprotein, which can be tested for and possibly treated.
Pfizer’s new R&D head, a VC deep-dive, and a new FDA commissioner?
What’s in store for biotech VCs next year? Will Pfizer’s new R&D head do enough to appease investors? And should Adam get a position under